This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Apr;8(4):182.

doi: 10.1038/nrcardio.2011.24.

Hypertension: AT1 autoantibodies and response to therapy

PMID: 21553725
DOI: 10.1038/nrcardio.2011.24

Comment

Hypertension: AT1 autoantibodies and response to therapy

Alexandra King. Nat Rev Cardiol. 2011 Apr.

. 2011 Apr;8(4):182.

doi: 10.1038/nrcardio.2011.24.

Author

PMID: 21553725
DOI: 10.1038/nrcardio.2011.24

No abstract available

PubMed Disclaimer

Comment on

Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
Wei F, Jia XJ, Yu SQ, Gu Y, Wang L, Guo XM, Wang M, Zhu F, Cheng X, Wei YM, Zhou ZH, Fu M, Liao YH; SOT-AT1 Study Group. Wei F, et al. Heart. 2011 Mar;97(6):479-84. doi: 10.1136/hrt.2009.192104. Epub 2011 Feb 4. Heart. 2011. PMID: 21296780 Clinical Trial.

References

1. Heart. 2011 Mar;97(6):479-84 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program